Low Dose Naltrexone (LDN)
Low‑dose naltrexone (LDN) is a low dose of naltrexone that is thought to briefly block opioid receptors to boost natural endorphins and support immune balance.
Lupus medication regimens are as complex as the condition itself, using multiple therapies to minimize inflammation and disease development. Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that requires lifelong management. Inflammation is prevalent across the body as a result of a dysregulated immune system response. Symptoms are challenging to overcome because they typically change in presentation and severity over time.
The gender gap is great in systemic lupus erythematosus (SLE), with women making up 80% of the individuals diagnosed with chronic inflammatory autoimmune diseases. In SLE, the immune system attacks the body’s own organs and systems.
This extensive immune dysregulation can be cyclic over the course of the disease with varying intensity. Some patients experience milder, more manageable symptoms like fatigue and/or transient rashes, while others can suffer serious organ involvement like compromised kidney function as the condition progresses.
Autoimmune related symptoms like widespread inflammation may not be sufficiently managed with traditional options alone. Some patients may also benefit from adjacent support with compounded options, such as low dose naltrexone (LDN).
Low‑dose naltrexone (LDN) is a low dose of naltrexone that is thought to briefly block opioid receptors to boost natural endorphins and support immune balance.
For patients with SLE, the immune system targets and attacks the body’s own organs and systems. Although lupus and autoimmune therapeutic management center on immune modulating and anti-inflammatory medications, there are lifestyle changes that can decrease flares and improve daily symptoms.
Marked by fluctuating symptoms that are difficult to diagnose, SLE is characterized by inflammation across the body due to an altered immune response. Lupus can echo symptoms seen in many other autoimmune conditions, making it a difficult condition to definitively diagnose. Lupus patients can experience different symptoms in varying degrees over the course of the disease.
Signs of SLE may include:
Finding medications that reduce inflammation and slow disease progression can provide SLE patients the quality of life they deserve. Lupus medications like immunomodulators like hydroxychloroquine, corticosteroids like prednisone, or biologic agents are considered foundational to treatment. Be aware that some options are contraindicated in pregnancy. There is no cure for SLE, but these mainstay lupus therapies can improve daily symptoms and prevent worsening autoimmunity.
As a complement to standard lupus medication regimens, LDN may help limit inflammation and fatigue due to its potential to increase the immune response and provide an analgesic effect in autoimmune conditions.
LDN can act as a lupus anti-inflammatory medication and as an immune modulator. Both mechanisms are critical for autoimmune disease management in SLE. By strengthening immune system performance and upregulating endorphins, LDN can improve quality of life for patients plagued with systemic inflammation and fatigue.
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition, where inflammation is prevalent across the body as a result of a dysregulated immune system response. Symptoms like extreme fatigue and joint pain tend to fluctuate over time and there is no cure for the disease. Medication management focuses on reducing inflammatory pain and disease progression, while improving quality of life.
Many patients initially present with generic symptoms of fatigue, general discomfort, weight loss, and occasional fever. Since these symptoms often come and go and mimic many other conditions, recognizing them as a sign of a greater diagnosable disease can be challenging for patients and providers alike.
If one or more family members has an autoimmune condition, genetic preposition may put an individual at increased likelihood for developing one as well. However, it doesn’t definitively dictate if or how autoimmunity will present and impact daily life. There are many other environmental triggers like infections that may influence whether or not an autoimmune condition like SLE develops.
